| Repaglinide Teva 1 mg Tablet EU/1/09/530/6-10 |
Repaglinide |
Teva Pharma B.V. |
— |
| Repaglinide Teva 2 mg Tablet EU/1/09/530/11-15 |
Repaglinide |
Teva Pharma B.V. |
— |
| Repatha 140 mg solution for injection in pre-filled pen EU/1/15/1016/002-005 |
Evolocumab |
Amgen Europe B.V. |
— |
| Repatha 140 mg solution for injection in pre-filled syringe EU/1/15/1016/001 |
Evolocumab |
Amgen Europe B.V., |
— |
| Repatha 420 mg solution for injection in cartridge EU/1/15/1016/006-007 |
Evolocumab |
Amgen Europe B.V. |
— |
| Replagal 1 mg/ml concentrate for solution for infusion EU/1/01/189/001 |
Agalsidase alfa |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Repso EU/1/11/674/006-010 |
Leflunomide |
Teva Pharma B.V. |
— |
| Resolor 1 mg film-coated tablets EU/1/09/581/001 |
Prucalopride Succinate |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Resolor 2 mg film-coated tablets EU/1/09/581/002 |
Prucalopride Succinate |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Respreeza 1,000 mg powder and solvent for solution for infusion. EU/1/15/1006/001 |
Human alpha1-proteinase inhibitor |
CSL Behring GmbH |
— |
| Retacrit EU/1/07/431/17-19 |
Epoetin zeta |
Pfizer Europe MA EEIG |
— |
| Retacrit EU/1/07/431/7-16 |
Epoetin zeta |
Pfizer Europe MA EEIG |
— |
| Retacrit 1000 IU/0.3 ml Solution for injection EU/1/07/431/1-6 |
Epoetin zeta |
Pfizer Europe MA EEIG |
— |
| Retsevmo 120 mg film-coated tablets EU/1/20/1527/018-020 |
Selpercatinib |
Eli Lilly Nederland B.V. |
— |
| Retsevmo 160 mg film-coated tablets EU/1/20/1527/021-023 |
Selpercatinib |
Eli Lilly Nederland B.V. |
— |
| Retsevmo 40 mg film-coated tablets EU/1/20/1527/012-014 |
Selpercatinib |
Eli Lilly Nederland B.V. |
— |
| Retsevmo 40 mg hard capsules EU/1/20/1527/001 |
Selpercatinib |
Eli Lilly Nederland B.V. |
— |
| Retsevmo 80 mg film-coated tablets EU/1/20/1527/015-017 |
Selpercatinib |
Eli Lilly Nederland B.V. |
— |
| Retsevmo 80 mg hard capsules EU/1/20/1527/002-003 |
Selpercatinib |
Eli Lilly Nederland B.V. |
— |
| Revatio 0.8 mg/ml solution for injection EU/1/05/318/002 |
Sildenafil citrate for parenteral use |
Upjohn EESV |
— |
| Revatio 10 mg/ml powder for oral suspension EU/1/05/318/003 |
Sildenafil citrate |
Upjohn EESV |
— |
| Revatio 20 mg film-coated tablets EU/1/05/318/001 |
Sildenafil |
Upjohn EESV |
— |
| Revestive 1.25 mg powder and solvent for solution for injection EU/1/12/787/003 |
Teduglutide |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Revestive 5 mg powder and solvent for solution for injection EU/1/12/787/001 |
Teduglutide |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Revinty Ellipta 184 micrograms/22 micrograms inhalation powder, pre-dispensed EU/1/14/929/004-006 |
Fluticasone furoate, Vilanterol |
GlaxoSmithKline (Ireland) Limited |
— |
| Revinty Ellipta 92 micrograms/22 micrograms inhalation powder, pre-dispensed EU/1/14/929/001-003 |
Fluticasone furoate, Vilanterol |
GlaxoSmithKline (Ireland) Limited |
— |
| Revlimid 10 mg hard capsules EU/1/07/391/002 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 15 mg hard capsules EU/1/07/391/003 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 2.5 mg hard capsules EU/1/07/391/005 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 20 mg hard capsules EU/1/07/391/009 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 25 mg hard capsules EU/1/07/391/004 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 5 mg hard capsules EU/1/07/391/001 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 7.5 mg hard capsules EU/1/07/391/006 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revolade 12.5 mg film-coated tablets EU/1/10/612/010-012 |
Eltrombopag olamine |
Novartis Europharm Limited |
— |
| Revolade 25 mg film-coated tablets EU/1/10/612/1-3 |
Eltrombopag olamine |
Novartis Europharm Limited |
— |
| Revolade 25 mg powder for oral suspension EU/1/10/612/013 |
Eltrombopag olamine |
Novartis Europharm Limited |
— |
| Revolade 50 mg film-coated tablets EU/1/10/612/4-6 |
Eltrombopag olamine |
Novartis Europharm Limited |
— |
| Revolade 75 mg film-coated tablets EU/1/10/612/007-009 |
Eltrombopag (sb-497115) |
Novartis Europharm Limited |
— |
| Reyataz EU/1/03/267/01-7 |
Atazanavir |
Bristol-Myers Squibb Pharma EEIG |
— |
| Reyataz 300 mg hard capsules EU/1/03/267/8-9 |
Atazanavir sulfate |
Bristol-Myers Squibb Pharma EEIG |
— |
| Reyataz 50 mg oral powder EU/1/03/267/012 |
Atazanavir sulfate |
Bristol-Myers Squibb Pharma EEIG |
— |
| Rezdiffra 100 mg film-coated tablets EU/1/25/1962/003 |
Resmetirom |
Madrigal Pharmaceuticals EU Limited |
— |
| Rezdiffra 60 mg film-coated tablets EU/1/25/1962/001 |
Resmetirom |
Madrigal Pharmaceuticals EU Limited |
— |
| Rezdiffra 80 mg film-coated tablets EU/1/25/1962/002 |
Resmetirom |
Madrigal Pharmaceuticals EU Limited |
— |
| REZOLSTA 675 mg/150 mg film-coated tablets EU/1/14/967/002 |
Darunavir ethanolate, Cobicistat |
Janssen-Cilag International NV |
— |
| REZOLSTA 800 mg/150 mg film-coated tablets EU/1/14/967/001 |
Darunavir, Cobicistat |
Janssen-Cilag International NV |
— |
| REZZAYO 200 mg powder for concentrate for solution for infusion EU/1/23/1775/001 |
Rezafungin acetate |
Mundipharma GmbH |
— |
| Rhokiinsa 200 micrograms/ml eye drops, solution EU/1/19/1400/001 |
NETARSUDIL MESILATE |
Santen OY |
— |
| Riltrava Aerosphere 5/7.2/160 micrograms pressurised inhalation, suspension EU/1/21/1604/001-002 |
Formoterol fumarate dihydrate, Glycopyrronium bromide, Budesonide |
AstraZeneca AB |
— |
| RILUTEK 50 mg film-coated tablets EU/1/96/010/001 |
Riluzole |
Sanofi Winthrop Industrie |
— |